Emergent to make Calgary-based Providence Therapeutics’ potential COVID-19 vaccine
Emergent BioSolutions Inc. signed a five-year agreement with Calgary-based biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million. Emergent will produce drug substances …